Who owns Esperion Therapeutics, Inc. (CMRX)? Elite investor 13F holders
2 tracked elite investors reported holding Esperion Therapeutics, Inc as of 2026-06-30, including Renaissance Technologies LLC, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | ESPERION THERAPEUTICS INC NE | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Renaissance Technologies LLC | ESPERION THERAPEUTICS INC NE | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 506232.00 USD | 160200.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | ESPERION THERAPEUTICS INC NE | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| GAMCO | ESPERION THERAPEUTICS INC NE | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 545100.00 USD | 172500.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.